Press release content from Business Wire. The AP news staff was not involved in its creation.
Can-Fite Announces Publication of Namodenoson Liver Cancer Study in Peer Reviewed Journal Cancers
January 8, 2021 GMT
PETACH TIKVA, Israel (BUSINESS WIRE) Jan 8, 2021
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced a scientific paper titled, “Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial” was published in the peer reviewed journal
ADVERTISEMENT
The paper highlights and analyzes results from Can-Fite’s Phase II study, a randomized placebo-controlled trial to investigate Namodenoson as a 2nd-line treatment for advanced hepatocellular carcinoma (HCC) and moderate hepatic dysfunction, as defined by Child–Pugh B (CPB) scores of 7–9. Even thoug
Press release content from Wired Release. The AP news staff was not involved in its creation.
Global Ammonium Dichromate Market Evolutionary Growth, Key Futuristic Trends and Product Innovation 2022-2031
January 8, 2021 GMT
Pune, Maharashtra, India, January 8 2021 (Wiredrelease) Prudour Pvt. Ltd :According to new reliable research on Ammonium Dichromate Market, featuring a short universal view of the size of the market, geographical scope and key trends based on volume and value, far-reaching SWOT analysis, development plans, % value of CAGR analysis and growth factors. Moreover, the report focuses on significant growth factors and obstacles accepted by market leaders in this market.
The report includes data analysis about the market status, competition pattern, advantages and disadvantages of enterprise products, development trends, and regional industrial layout characteristics. Development policy and plans of Our researcher experts helps us to present our clients with a compre
Press release content from Business Wire. The AP news staff was not involved in its creation.
Generational Equity Advises Riviera Pools in Sale to Two Private Investors
January 8, 2021 GMT
DALLAS (BUSINESS WIRE) Jan 8, 2021
Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of Riviera Pools, Inc. and D & B Services to two Private Investors. The acquisition closed December 21, 2020 and details were not disclosed.
ADVERTISEMENT
Riviera Pools (Riviera), located in Foley, Alabama, and founded in 1993, provides swimming pool construction, service, repair and sells related retail products. In 2020, revenue was derived from construction and remodeling and service and repair. The Company has built its reputation by providing friendly customer service and high-quality products. Riviera has served the Gulf Coast and the Southern Baldwin County for over 20 years.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Japan Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires and Coronary Stents - ResearchAndMarkets.com
January 8, 2021 GMT
DUBLIN (BUSINESS WIRE) Jan 8, 2021
ADVERTISEMENT
This is a comprehensive databook report, covering key market data on the Japan Interventional Cardiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS) and PTCA Balloon Catheters.
The Japan Interventional Cardiology Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.